| 1 | [SID103526751] | Active | Ki | 0.0095 | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670110, Type: Literature] | Mu-type opioid receptor [gi:2851402] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.0095 [uM] | | BioAssay | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670110 | | BioAssay type | Literature | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | 22439881 | | Data Table |  |
|
| 2 | [SID103526751] | Active | Ki | 0.0095 | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670110, Type: Literature] | Mu-type opioid receptor [gi:2851402] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.0095 [uM] | | BioAssay | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670110 | | BioAssay type | Literature | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | 22439881 | | Data Table |  |
|
| 3 | [SID103526751] | Active | Ki | 0.0095 | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670110, Type: Literature] | Mu-type opioid receptor [gi:2851402] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.0095 [uM] | | BioAssay | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670110 | | BioAssay type | Literature | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | 22439881 | | Data Table |  |
|
| 4 | [SID103526751] | Active | Ki | 0.0095 | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670110, Type: Literature] | Mu-type opioid receptor [gi:2851402] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.0095 [uM] | | BioAssay | Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670110 | | BioAssay type | Literature | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | 22439881 | | Data Table |  |
|
| 5 | [SID103526751] | Active | Ki | 0.26 | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670111, Type: Literature] | Kappa-type opioid receptor [gi:116242691] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.26 [uM] | | BioAssay | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670111 | | BioAssay type | Literature | | Target | Kappa-type opioid receptor [gi:116242691] | | PubMed | 22439881 | | Data Table |  |
|
| 6 | [SID103526751] | Active | Ki | 0.26 | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670111, Type: Literature] | Kappa-type opioid receptor [gi:116242691] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.26 [uM] | | BioAssay | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670111 | | BioAssay type | Literature | | Target | Kappa-type opioid receptor [gi:116242691] | | PubMed | 22439881 | | Data Table |  |
|
| 7 | [SID103526751] | Active | Ki | 0.26 | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670111, Type: Literature] | Kappa-type opioid receptor [gi:116242691] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.26 [uM] | | BioAssay | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670111 | | BioAssay type | Literature | | Target | Kappa-type opioid receptor [gi:116242691] | | PubMed | 22439881 | | Data Table |  |
|
| 8 | [SID103526751] | Active | Ki | 0.26 | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting [AID670111, Type: Literature] | Kappa-type opioid receptor [gi:116242691] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | Ki | 0.26 [uM] | | BioAssay | Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting | | AID | 670111 | | BioAssay type | Literature | | Target | Kappa-type opioid receptor [gi:116242691] | | PubMed | 22439881 | | Data Table |  |
|
| 9 | [SID103526751] | Active | ED50 | 2.4 | Analgesic activity was measured by acetic acid writhing test in mouse by giving subcutaneous injection [AID128495, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | ED50 | 2.4 [uM] | | BioAssay | Analgesic activity was measured by acetic acid writhing test in mouse by giving subcutaneous injection | | AID | 128495 | | BioAssay type | Literature | | Target | | | PubMed | 6153723 | | Data Table |  |
|
| 10 | [SID103526751] | Active | ED50 | 5.2 | Analgesic activity measured by rat tail flick assay following s.c. administration. [AID177776, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | ED50 | 5.2 [uM] | | BioAssay | Analgesic activity measured by rat tail flick assay following s.c. administration. | | AID | 177776 | | BioAssay type | Literature | | Target | | | PubMed | 6153723 | | Data Table |  |
|
| 11 | [SID103526751] | Active | | | Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis [AID678721, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Active | | BioAssay | Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis | | AID | 678721 | | BioAssay type | Literature | | Target | | | PubMed | 22931300 | | Data Table |  |
|
| 12 | [SID48416090] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 48416090 | | CID | 5284569 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID103526751] | Unspecified | | | Narcotic agonist activity using acetic acid induced writhing in the mouse upon subcutaneous administration [AID127831, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Narcotic agonist activity using acetic acid induced writhing in the mouse upon subcutaneous administration | | AID | 127831 | | BioAssay type | Literature | | Target | | | PubMed | 6864732 | | Data Table |  |
|
| 14 | [SID103526751] | Unspecified | | | Agonistic activity by mouse acetic acid writhing test. [AID128307, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Agonistic activity by mouse acetic acid writhing test. | | AID | 128307 | | BioAssay type | Literature | | Target | | | PubMed | 6181259 | | Data Table |  |
|
| 15 | [SID103526751] | Unspecified | | | Compound was tested for analgesia in mouse writhing assay by subcutaneous administration [AID128023, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Compound was tested for analgesia in mouse writhing assay by subcutaneous administration | | AID | 128023 | | BioAssay type | Literature | | Target | | | PubMed | 7192744 | | Data Table |  |
|
| 16 | [SID103526751] | Unspecified | | | Compound was tested for analgesic activity by writhing assay in mouse after subcutaneous administration [AID128027, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Compound was tested for analgesic activity by writhing assay in mouse after subcutaneous administration | | AID | 128027 | | BioAssay type | Literature | | Target | | | PubMed | 6114178 | | Data Table |  |
|
| 17 | [SID103526751] | Unspecified | | | Narcotic agonistic activity in acetic acid mouse writhing assay after subcutaneous administration of the drug [AID128214, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Narcotic agonistic activity in acetic acid mouse writhing assay after subcutaneous administration of the drug | | AID | 128214 | | BioAssay type | Literature | | Target | | | PubMed | 7310822 | | Data Table |  |
|
| 18 | [SID103526751] | Unspecified | | | Compound was tested for analgesic activity by tail-flick assay in rat after subcutaneous administration [AID178138, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Compound was tested for analgesic activity by tail-flick assay in rat after subcutaneous administration | | AID | 178138 | | BioAssay type | Literature | | Target | | | PubMed | 6114178 | | Data Table |  |
|
| 19 | [SID103526751] | Unspecified | | | Analgesic agonist activity in heat stimulus rat tail-flick assay on subcutaneous administration [AID178144, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Analgesic agonist activity in heat stimulus rat tail-flick assay on subcutaneous administration | | AID | 178144 | | BioAssay type | Literature | | Target | | | PubMed | 6166748 | | Data Table |  |
|
| 20 | [SID103526751] | Unspecified | | | Antagonist activity in rat tail flick assay by subcutaneous administration [AID178161, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Antagonist activity in rat tail flick assay by subcutaneous administration | | AID | 178161 | | BioAssay type | Literature | | Target | | | PubMed | 7192744 | | Data Table |  |
|
| 21 | [SID103526751] | Unspecified | | | Compound was tested for antinociceptive activity in heat stimulus rat tail flick assay after subcutaneous administration of the drug [AID178325, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Compound was tested for antinociceptive activity in heat stimulus rat tail flick assay after subcutaneous administration of the drug | | AID | 178325 | | BioAssay type | Literature | | Target | | | PubMed | 7310822 | | Data Table |  |
|
| 22 | [SID103526751] | Unspecified | | | Effective dose was measured by using rat tail flick assay after subcutaneous administration [AID180157, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Effective dose was measured by using rat tail flick assay after subcutaneous administration | | AID | 180157 | | BioAssay type | Literature | | Target | | | PubMed | 6767032 | | Data Table |  |
|
| 23 | [SID103526751] | Unspecified | | | Lipophilicity, log D at pH7.4 [AID298031, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Lipophilicity, log D at pH7.4 | | AID | 298031 | | BioAssay type | Literature | | Target | | | PubMed | 17725338 | | Data Table |  |
|
| 24 | [SID103526751] | Unspecified | | | Acid dissociation constant, pKa of the compound [AID298032, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Acid dissociation constant, pKa of the compound | | AID | 298032 | | BioAssay type | Literature | | Target | | | PubMed | 17725338 | | Data Table |  |
|
| 25 | [SID103526751] | Unspecified | | | Analgesic agonist activity in acetic acid induced mouse writhing assay, subcutaneous administration [AID131018, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Analgesic agonist activity in acetic acid induced mouse writhing assay, subcutaneous administration | | AID | 131018 | | BioAssay type | Literature | | Target | | | PubMed | 6166748 | | Data Table |  |
|
| 26 | [SID103526751] | Unspecified | | | The effective dose was measured by using mouse writhing assay after the compound administered subcutaneously. [AID132133, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | The effective dose was measured by using mouse writhing assay after the compound administered subcutaneously. | | AID | 132133 | | BioAssay type | Literature | | Target | | | PubMed | 6767032 | | Data Table |  |
|
| 27 | [SID103526751] | Unspecified | | | Selectivity index, ratio of inhibition of human delta opioid receptor to inhibition of human mu opioid receptor [AID670115, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Selectivity index, ratio of inhibition of human delta opioid receptor to inhibition of human mu opioid receptor | | AID | 670115 | | BioAssay type | Literature | | Target | | | PubMed | 22439881 | | Data Table |  |
|
| 28 | [SID103526751] | Unspecified | | | Selectivity index, ratio of inhibition of human kappa opioid receptor to inhibition of human mu opioid receptor [AID670116, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Selectivity index, ratio of inhibition of human kappa opioid receptor to inhibition of human mu opioid receptor | | AID | 670116 | | BioAssay type | Literature | | Target | | | PubMed | 22439881 | | Data Table |  |
|
| 29 | [SID29215221] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 30 | [SID103526751] | Unspecified | | | Displacement of [3H]-naltrindole from human delta opioid receptor expressed in CHO cells at 10 uM after 3 hrs by scintillation counting [AID670114, Type: Literature] | Delta-type opioid receptor [gi:311033488] |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Displacement of [3H]-naltrindole from human delta opioid receptor expressed in CHO cells at 10 uM after 3 hrs by scintillation counting | | AID | 670114 | | BioAssay type | Literature | | Target | Delta-type opioid receptor [gi:311033488] | | PubMed | 22439881 | | Data Table |  |
|
| 31 | [SID103526751] | Unspecified | | | Displacement of [3H]-naltrindole from human delta opioid receptor expressed in CHO cells at 10 uM after 3 hrs by scintillation counting [AID670114, Type: Literature] | Delta-type opioid receptor [gi:311033488] |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103526751 | | CID | 5284569 | | Outcome | Unspecified | | BioAssay | Displacement of [3H]-naltrindole from human delta opioid receptor expressed in CHO cells at 10 uM after 3 hrs by scintillation counting | | AID | 670114 | | BioAssay type | Literature | | Target | Delta-type opioid receptor [gi:311033488] | | PubMed | 22439881 | | Data Table |  |
|
| 32 | [SID29215221] | Inactive | Potency | 112.202 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | 112.202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 33 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 34 | [SID29215221] | Inactive | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 35 | [SID29215221] | Inactive | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 36 | [SID29215221] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 37 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 38 | [SID29215221] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 39 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 40 | [SID29215221] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 41 | [SID29215221] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) [AID1476, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent) | | AID | 1476 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 42 | [SID29215221] | Inactive | Potency | | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) [AID1478, Type: confirmatory] | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent) | | AID | 1478 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Cruzain Covalently Bound To A Purine Nitrile [gi:281307097] | | PubMed | | | Data Table |  |
|
| 43 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 44 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 45 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 46 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID1452, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 1452 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 47 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID1452, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 1452 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 48 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) [AID881, Type: confirmatory] | Arachidonate 15-lipoxygenase B [gi:317373425] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) | | AID | 881 | | BioAssay type | confirmatory | | Target | Arachidonate 15-lipoxygenase B [gi:317373425] | | PubMed | | | Data Table |  |
|
| 49 | [SID29215221] | Inactive | Potency | | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 50 | [SID29215221] | Inactive | Potency | | Biochemical firefly luciferase enzyme assay for NPC [AID624030, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 29215221 | | CID | 5284569 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Biochemical firefly luciferase enzyme assay for NPC | | AID | 624030 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|